PharmEnable (private company)

See something wrong or missing? Let us know
Offices:Cambridge
Business model:B2BSAAS

PharmEnable is a Cambridge (UK) based drug discovery company, using a combination of medicinal chemistry and AI computational approaches to design the next generation of specific and cost-efficient small molecule drugs. Our mission is to discover new treatments for otherwise undruggable conditions.

Investors: we tracked 8 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 9.76M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to PharmEnable

Name Criteria
France Synapse Medicine
85%
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 2
United Kingdom Causaly
85%
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • At least one angel investor: found 2
  • At least one vc investor: found 4
  • At least one other investor: found 2
Germany Perfood
80%
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Skin Analytics
77%
  • Similar verticals: Competitive Intelligence, Health services
  • Similar business models: B2B, SAAS
  • At least one angel investor: found 2
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Germany Nostos Genomics
77%
  • Similar verticals: Competitive Intelligence, Health services
  • Similar business models: B2B, SAAS
  • At least one angel investor: found 2
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Sweden Medoma
77%
  • Similar verticals: Competitive Intelligence, Health services
  • Similar business models: B2B, SAAS
  • At least one angel investor: found 2
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Austria Xund
77%
  • Similar verticals: Competitive Intelligence, Health services
  • Similar business models: B2B, SAAS
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Veratrak
77%
  • Similar verticals: Competitive Intelligence, Pharma
  • Similar business models: B2B, SAAS
  • At least one angel investor: found 2
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Germany Semalytix
77%
  • Similar verticals: Competitive Intelligence, Health services, Pharma
  • Similar business models: B2B, SAAS
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Denmark Teton.ai
74%
  • Similar verticals: Competitive Intelligence, Health services
  • Similar business models: B2B, SAAS
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Top